
A critical need for clinical trials
Sub-Saharan Africa has the highest burden of Sickle Cell Disease (SCD), yet clinical trials remain scarce as an unmet need in this region. Expanding research in the region across SCD and other chronic diseases is key to improving care and providing access to innovative therapies.

Limited access to healthcare infrastructure
Many patients in Africa lack access to advanced treatment options. Clinical trials offer a pathway to accessing better therapies, but logistical barriers slow progress and limited understanding of the cultural nuances within the region pose additional challenges for sponsors looking to run their clinical trials in Sub-Saharan Africa.

Afro-REACH simplifies the process
With deep regional expertise, Afro-REACH handles site selection, regulatory approvals, shipping and logistics, and patient recruitment, ensuring smooth trial execution.